SCHEMBL4353720

SCHEMBL4353720

CCOC(=O)CCNC(=O)Nc1cccc(Cl)c1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.60
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 7/20 0.49
KDM4E B2RXH2 4/20 0.48
MAPT P10636 4/20 0.48
HSD17B10 Q99714 3/20 0.48
HPGD P15428 2/20 0.48
DGAT2 Q96PD7 1/20 0.48
NLRP3 Q96P20 1/20 0.46
ITGB3 P05106 1/20 0.45
ITGAV P06756 1/20 0.45
GAA P10253 2/20 0.44
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.43
CXCR2 P25025 1/20 0.43
GPR35 Q9HC97 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPK1 P28482 1/20 0.43
CASR P41180 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6227554 0.93 HTT (0.54) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4346935 0.85 ALDH1A1 (0.49) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4346301 0.82 MEN1 (0.46) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL27782809 0.80 POLB (0.61) HTTMEN1KMT2AALDH1A1MAPT
SCHEMBL4357568 0.79 EPHX1 (0.58) HTTMEN1KMT2AALDH1A1MAPT
SCHEMBL4351254 0.79 HTT (0.47) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4345924 0.78 ALDH1A1 (0.52) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4349661 0.78 MEN1 (0.67) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL6565685 0.77 CXCR2 (0.50) HTTMEN1KMT2AALDH1A1KDM4E
SCHEMBL4347692 0.77 ALDH1A1 (0.48) HTTMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 HTT 3824/4885MEN1 2168/4885KMT2A 2096/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 HTT 3995/4885MEN1 3901/4885KMT2A 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.